Moldovan med j 2021 64 3 lupascu-volentir et al abstract.indd

HIGHLIGHTS

• who: ( and colleagues from the Diomid Gherman Institute of Neurology and Neurosurgery Department of Neurology No, Nicolae Testemitanu State University of Medicine and Pharmacy have published the paper: moldovan med j 2021 64 3 lupascu-volentir et al abstract.indd, in the Journal: (JOURNAL)
• what: Perceptions regarding pregnancy in women with MS and risks of DMD treatment are changing.
• future: In the 5-year extension of the CARE-MS I study 31.5% of the patients received additional alemtuzumab cycles 22.1% received one additional cycle 8.0% two additional cycles and 1 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.